Status:
COMPLETED
Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young Adults
Lead Sponsor:
Northumbria University
Conditions:
Cognitive Function
Mood
Eligibility:
All Genders
18-35 years
Phase:
PHASE4
Brief Summary
Epigallocatechin gallate (EGCG) is the most abundant catechin (sometimes referred to as tea flavonoids) in green tea extract. A review by Nagle et al (2006) identifies that a large amount of research ...
Eligibility Criteria
Inclusion
- healthy
- aged 18-35
- either caffeine consumers (consume more than 150mg caffeine per day) or non-consumers (consume less than 44mg caffeine per day).
Exclusion
- smoke or consume any tobacco products
- not proficient in English language
- pregnant (or seeking to become pregnant)
- taking recreational, over the counter/prescription medication (including the contraceptive pill), and/or dietary/herbal supplements
- have food allergies or sensitivities
- have history of/current head trauma, learning difficulties , ADHD, migraines or any gastric problems
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00981292
Start Date
August 1 2009
End Date
December 1 2009
Last Update
April 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northumbria University
Newcastle upon Tyne, United Kingdom, NE1 8ST